Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00053378
Status:
COMPLETED
Last Update Posted:
2006-08-02
First Post:
2003-01-27
Brief Title:
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
A Placebo-Controlled Double-Blind Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
Status:
COMPLETED
Status Verified Date:
2006-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None